SCHEMBL5317418

SCHEMBL5317418

COc1ccc(Cn2cc(N(Cl)C(=O)c3ccccc3OC)c(-c3nn(CCN4CCOCC4)c(=O)n3Cc3ccc(OC)cc3)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
KDM5B Q9UGL1 2/20 0.38
PDE1B Q01064 3/20 0.37
MAPT P10636 1/20 0.37
HTT P42858 1/20 0.37
CNR1 P21554 1/20 0.37
POLB P06746 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
NR1H4 Q96RI1 1/20 0.36
MAPK1 P28482 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36
GAA P10253 1/20 0.36
BCL3 P20749 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3579583 0.79 SMN1; SMN2 (0.46) ALDH1A1PDE1BMAPTHTTSMN1; SMN2
SCHEMBL3585667 0.77 MEN1 (0.48) ALDH1A1MAPTPOLBSMN1; SMN2NR1H4
SCHEMBL5317422 0.77 NPC1 (0.46) ALDH1A1KDM5BMAPTPOLBSMN1; SMN2
SCHEMBL3586746 0.76 SMN1; SMN2 (0.43) ALDH1A1PDE1BMAPTHTTSMN1; SMN2
SCHEMBL3588294 0.63 TP53 (0.48) ALDH1A1MAPTHTTSMN1; SMN2MAPK1
SCHEMBL3587206 0.62 KDM4E (0.43) ALDH1A1PDE1BMAPTGAA
SCHEMBL29339969 0.62 DRD1 (0.47) PDE1BPOLBSMN1; SMN2
SCHEMBL367325 0.61 SMN1; SMN2 (0.44) ALDH1A1PDE1BMAPTSMN1; SMN2NR1H4
SCHEMBL29339971 0.61 DRD1 (0.53) PDE1BSMN1; SMN2
SCHEMBL29339973 0.61 HTR1A (0.42) ALDH1A1POLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1836188-A1 PYRAZOLE DERIVATIVES AS THAT MODULATE THE ACTIVITY OF CDK, GSK AND AURORA KINASES Astex Therapeutics Limited (GB) 2007-09-26 EP disclosed
WO-2006070198-A1 PYRAZOLE DERIVATIVES AS THAT MODULATE THE ACTIVITY OF CDK, GSK AND AURORA KINASES ASTEX THERAPEUTICS LIMITED (GB) 2006-07-06 WO disclosed